Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:45 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 385 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Hip Arthrosis Clear all

Conditions: Osteoarthritis
Interventions: PRT + FM, Usual Care; Behavioral · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 40 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Osteoarthritis
Interventions: Osteoarthritis Physical Activity Care Pathway; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 65 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Hip Osteoarthritis, Hip Impingement Syndrome, Cartilage Damage, Fibrosis
Interventions: Losartan, Placebo; Drug · Other
Lead sponsor: Steadman Philippon Research Institute; Other
Eligibility: 18 Years to 60 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Vail, Colorado

Conditions: Developmental Dysplasia of the Hip
Interventions: Acoustical Resonance Device; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 1 Day to 6 Months
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoarthritis
Interventions: Rehabilitation after joint replacement surgery; Behavioral
Lead sponsor: MedStar National Rehabilitation Network; Other
Eligibility: 21 Years and older
Enrollment: 2,384 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Surgery, Hip Osteoarthritis
Interventions: Robotic-Arm Assisted THA; Procedure
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Instability, Joint
Interventions: SUTUREFIX ULTRA Suture Anchor and SUTUREFIX CURVED Suture Anchor; Device
Lead sponsor: Smith & Nephew Orthopaedics AG; Industry
Eligibility: 18 Years and older
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 2
States / cities: New York, New York • Knoxville, Tennessee

Conditions: Avascular Necrosis, Osteoarthritis, Inflammatory Arthritis, Post-traumatic Arthritis, Rheumatoid Arthritis
Interventions: Continuum Metal on Polyethylene Acetabular System; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2026
U.S. locations: 2
States / cities: Fremont, California • Denver, Colorado

Conditions: Lumbar Spondylosis, Cervical Spondylosis, Hip Osteoarthritis, Knee Osteoarthritis
Interventions: inhalation anesthesia with isoflurane vs. TIVA with propofol; Drug
Lead sponsor: Duke University; Other
Eligibility: 65 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 2
States / cities: Durham, North Carolina

Conditions: Osteoarthritis of Hip
Interventions: Zilretta, Triamcinolone Acetonide; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 50 Years to 80 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Albany, New York

Conditions: Arthroplasty, Replacement, Hip, Arthritis
Interventions: Not listed
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Osteoarthritis
Interventions: tanezumab; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 2,147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 226
States / cities: Anniston, Alabama • Birmingham, Alabama • Huntsville, Alabama + 148 more

Conditions: Osteoarthritis, Hip
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2018
U.S. locations: 1
States / cities: Stanford, California

Conditions: Knee Osteoarthritis, Hip Osteoarthritis
Interventions: Low-Dose Bupivacaine, Mepivacaine; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Days and older
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis
Interventions: Not listed
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years and older
Enrollment: 432 participants
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip, Osteo Arthritis Shoulders, Synovitis of Knee, Synovitis/Tenosynovitis - Hip, Synovitis, Pain, Chronic
Interventions: Shoulder/Hip/Knee Embolization with Embozene Microspheres; Device
Lead sponsor: Palo Alto Veterans Institute for Research; Other
Eligibility: 25 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Osteoarthritis of the Shoulder, Osteoarthritis of the Hip
Interventions: FX006 32 mg, TAcs 40 mg; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 40 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 6
States / cities: El Cajon, California • La Mesa, California • San Diego, California + 3 more

Conditions: Anesthesia Morbidity, Osteoarthritis, Knee, Osteoarthritis, Hip
Interventions: Anesthesia Type; Procedure
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 12,466 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: South San Francisco, California

Conditions: Arthropathy of Hip Joint, Osteoarthritis, Hip
Interventions: Not listed
Lead sponsor: St. Elizabeth Medical Center, Utica, NY; Other
Eligibility: 30 Years to 100 Years
Enrollment: 207 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Utica, New York

Conditions: Bone Avascular Necrosis, Sickle Cell Anemia
Interventions: Core decompression; Procedure
Lead sponsor: UCSF Benioff Children's Hospital Oakland; Other
Eligibility: 10 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1999
U.S. locations: 2
States / cities: Oakland, California • Chapel Hill, North Carolina

Conditions: Osteoarthritis (OA) of the Hip
Interventions: Reparel Bioactive Sleeve, TED Stocking; Device
Lead sponsor: Reparel; Industry
Eligibility: 18 Years to 89 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Fremont, California

Conditions: Osteoarthritis, Hip
Interventions: manual or manipulative therapy, Manual / Manipulative Therapy, Supportive Care; Procedure
Lead sponsor: Cleveland Chiropractic College; Other
Eligibility: 40 Years to 85 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Arthroplasty, Replacement, Hip
Interventions: Restoration ADM X3 Device; Device
Lead sponsor: Stryker Orthopaedics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 367 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2023
U.S. locations: 9
States / cities: Gilbert, Arizona • Phoenix, Arizona • Tucson, Arizona + 6 more

Conditions: Osteoarthritis, Hip
Interventions: Periarticular injection (Deep injection), Periarticular injection (Superficial injection), Bupivacaine, Placebo; Procedure · Drug
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 50 Years to 75 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Overcoming TWEAK Signaling to Restore Muscle and Mobility After Joint Replacement

Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP)

Losartan to Improve Hip Microfracture

Sound Conduction of Infant Hips

JOINTS Study - Joint Replacement Outcome in Inpatient Rehabilitation Facilities and Nursing Treatment Sites

Two Year Study With Robotic-Arm Assisted Hip Surgery.

Safety and Performance of the SUTUREFIX ULTRA and SUTUREFIX CURVED Suture Anchors in Shoulder and Hip Arthroscopic Repair

Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study

Cognitive Effects of Inhalational Versus Intravenous General Anesthesia in the Elderly

A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip

Total Hip Arthroplasty Outcomes With Regional and Multimodal Analgesia

Extension Study Of Tanezumab In Osteoarthritis

Measured Hypocretin Levels and Recovery After Hip Surgery

Mepivacaine Versus Low-Dose Bupivacaine For Primary Total Hip and Knee Arthroplasty

Return to Golf After Orthopaedic Surgery

Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee

Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip

Evaluation of Anesthetic Techniques in Outpatient Total Joint Replacement Surgery in an Integrated Health Care Delivery System

Opioid Free and Therapy Minimized Advantages Using HANA Table for Total Hip Arthroplasty

Decompression Coring Versus Conservative Therapy in Patients With Avascular Necrosis of the Hip Related to Sickle Cell Disease

TED Stocking vs. Reparel Garment After Hip Replacement

Clinical Assessment of Two Manipulative Protocols in Treatment of Hip Osteoarthritis

Restoration® Anatomic Dual Mobility (ADM) X3® Acetabular System Study

Minimal Opioid Use After Total Hip Replacement (THR)